Header Logo

Connection

Jason Glanz to Vaccines

This is a "connection" page, showing publications Jason Glanz has written about Vaccines.
Connection Strength

7.761
  1. The Childhood Vaccination Schedule and the Lack of Association With Type 1 Diabetes. Pediatrics. 2021 12 01; 148(6).
    View in: PubMed
    Score: 0.639
  2. Using Social Media to Increase Vaccine Acceptance. Acad Pediatr. 2021 May-Jun; 21(4S):S32-S33.
    View in: PubMed
    Score: 0.613
  3. The science of vaccine safety: Summary of meeting at Wellcome Trust. Vaccine. 2020 02 18; 38(8):1869-1880.
    View in: PubMed
    Score: 0.562
  4. Association Between Estimated Cumulative Vaccine Antigen Exposure Through the First 23 Months of Life and Non-Vaccine-Targeted Infections From 24 Through 47 Months of Age. JAMA. 2018 03 06; 319(9):906-913.
    View in: PubMed
    Score: 0.493
  5. Web-based Social Media Intervention to Increase Vaccine Acceptance: A Randomized Controlled Trial. Pediatrics. 2017 Dec; 140(6).
    View in: PubMed
    Score: 0.482
  6. White Paper on studying the safety of the childhood immunization schedule in the Vaccine Safety Datalink. Vaccine. 2016 Feb 15; 34 Suppl 1:A1-A29.
    View in: PubMed
    Score: 0.427
  7. Cumulative and episodic vaccine aluminum exposure in a population-based cohort of young children. Vaccine. 2015 Nov 27; 33(48):6736-44.
    View in: PubMed
    Score: 0.419
  8. Addressing Parental Vaccine Concerns: Engagement, Balance, and Timing. PLoS Biol. 2015 Aug; 13(8):e1002227.
    View in: PubMed
    Score: 0.412
  9. Development of an interactive social media tool for parents with concerns about vaccines. Health Educ Behav. 2015 Jun; 42(3):302-12.
    View in: PubMed
    Score: 0.392
  10. Signal detection of adverse events with imperfect confirmation rates in vaccine safety studies using self-controlled case series design. Biom J. 2014 May; 56(3):513-25.
    View in: PubMed
    Score: 0.370
  11. A scan statistic for identifying optimal risk windows in vaccine safety studies using self-controlled case series design. Stat Med. 2013 Aug 30; 32(19):3290-9.
    View in: PubMed
    Score: 0.345
  12. An efficient statistical algorithm for a temporal scan statistic applied to vaccine safety analyses. Vaccine. 2012 Jun 08; 30(27):3986-91.
    View in: PubMed
    Score: 0.328
  13. Identifying optimal risk windows for self-controlled case series studies of vaccine safety. Stat Med. 2011 Mar 30; 30(7):742-52.
    View in: PubMed
    Score: 0.298
  14. Vaccination Timeliness Among US Children Aged 0-19 Months, National Immunization Survey-Child 2011-2021. JAMA Netw Open. 2024 Apr 01; 7(4):e246440.
    View in: PubMed
    Score: 0.188
  15. Impact of the COVID-19 Pandemic on Health Care Utilization in the Vaccine Safety Datalink: Retrospective Cohort Study. JMIR Public Health Surveill. 2024 Jan 23; 10:e48159.
    View in: PubMed
    Score: 0.185
  16. Failure to Complete Multidose Vaccine Series in Early Childhood. Pediatrics. 2023 08 01; 152(2).
    View in: PubMed
    Score: 0.179
  17. Association Between Aluminum Exposure From Vaccines Before Age 24 Months and Persistent Asthma at Age 24 to 59 Months. Acad Pediatr. 2023 Jan-Feb; 23(1):37-46.
    View in: PubMed
    Score: 0.169
  18. Beyond Vaccination Coverage: Population-Based Measurement of Early Childhood Immunization Schedule Adherence. Acad Pediatr. 2023 Jan-Feb; 23(1):24-34.
    View in: PubMed
    Score: 0.168
  19. Changes in incidence rates of outcomes of interest in vaccine safety studies during the COVID-19 pandemic. Vaccine. 2022 05 20; 40(23):3150-3158.
    View in: PubMed
    Score: 0.164
  20. Vaccine timeliness and prevalence of undervaccination patterns in children ages 0-19 months, U.S., National Immunization Survey-Child 2017. Vaccine. 2022 01 31; 40(5):765-773.
    View in: PubMed
    Score: 0.160
  21. Patterns of childhood immunization and all-cause mortality. Vaccine. 2017 12 04; 35(48 Pt B):6643-6648.
    View in: PubMed
    Score: 0.120
  22. Assessing misclassification of vaccination status: Implications for studies of the safety of the childhood immunization schedule. Vaccine. 2017 04 04; 35(15):1873-1878.
    View in: PubMed
    Score: 0.115
  23. Vaccine hesitancy: Causes, consequences, and a call to action. Vaccine. 2015 Nov 27; 33 Suppl 4:D66-71.
    View in: PubMed
    Score: 0.105
  24. Vaccine Hesitancy: Causes, Consequences, and a Call to Action. Am J Prev Med. 2015 Dec; 49(6 Suppl 4):S391-8.
    View in: PubMed
    Score: 0.104
  25. The Vaccine Safety Datalink: successes and challenges monitoring vaccine safety. Vaccine. 2014 Sep 22; 32(42):5390-8.
    View in: PubMed
    Score: 0.096
  26. Bias correction of risk estimates in vaccine safety studies with rare adverse events using a self-controlled case series design. Am J Epidemiol. 2013 Dec 15; 178(12):1750-9.
    View in: PubMed
    Score: 0.091
  27. The Vaccine Safety Datalink: a model for monitoring immunization safety. Pediatrics. 2011 May; 127 Suppl 1:S45-53.
    View in: PubMed
    Score: 0.076
  28. Comparison of epidemiologic methods for active surveillance of vaccine safety. Vaccine. 2008 Jun 19; 26(26):3341-5.
    View in: PubMed
    Score: 0.062

© 2025 Kaiser Permanente